ACME LaboratoriesDHA:ACMELAB +0.24%82 OCF Yield % is 24.33 as of Jul. 03, 2026, which is 203% above its 10-year median of 8.03. GuruFocus rates DHA:ACMELAB with a GF Score™ of 82/100 and a GF Value™ of BDT125.08 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,007 Drug Manufacturers companies, ACME Laboratories ranks better than 94.84% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for ACME Laboratories's OCF Yield % or its related term are showing as below:
DHA:ACMELAB'
s OCF Yield % Range Over the Past 10 Years
Min: 2.6 Med: 8.03 Max: 27.43
Current: 24.33
During the past 9 years, the highest OCF Yield % of ACME Laboratories was 27.43%. The lowest was 2.60%. And the median was 8.03%.
DHA:ACMELAB's OCF Yield % is ranked better than 94.84% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 3.43
vs DHA:ACMELAB: 24.33
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
ACME Laboratories OCF Yield % Related Terms
ACME Laboratories OCF Yield % Historical Data
* Premium members only.
The historical data trend for ACME Laboratories's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:ACMELAB vs ZTS, UTHR, VTRS: OCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ACME Laboratories OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's OCF Yield % distribution charts can be found below:
* The bar in red indicates where ACME Laboratories's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACME Laboratories (DHA:ACMELAB) has a OCF Yield % of 24.33 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on ACME Laboratories and its competitors. This is 203% above median its historical median of 8.03. Over the past decade, ACME Laboratories' OCF Yield % has ranged from 2.60 to 27.43. According to the industry distribution chart, ACME Laboratories ranks #52 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 5.2%.
Is ACME Laboratories' OCF Yield % too high?
ACME Laboratories' current OCF Yield % of 24.33 is 203% above median its 10-year median of 8.03. Over the past 10 years, this metric has ranged from a low of 2.60 to a high of 27.43. The Drug Manufacturers industry median OCF Yield % is 3.43. ACME Laboratories' value of 24.33 is 609.3% above this industry median. Based on the distribution chart, ACME Laboratories ranks #52 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, ACME Laboratories has a GF Score™ of 82/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ACME Laboratories' OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, ACME Laboratories ranks #52 out of 1007 companies for OCF Yield %. This places ACME Laboratories in the top 5% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.43. ACME Laboratories' value of 24.33 is 609.3% above this benchmark. Historically, ACME Laboratories' own OCF Yield % has ranged from 2.60 to 27.43 over the past decade. While the company's 10-year median is 8.03 vs. the industry median of 3.43, ACME Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.43, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ACME Laboratories's current OCF Yield % of 24.33 is 609.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on ACME Laboratories and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ACME Laboratories's current OCF Yield % is 24.33, which is 203% above median its own 10-year median of 8.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACME Laboratories stock overvalued right now?
Based on GuruFocus' analysis, ACME Laboratories (DHA:ACMELAB) is currently considered Possible Value Trap. The stock's GF Value™ is BDT125.08, compared to a current price of BDT82.60 — trading 34% below its estimated fair value. The current OCF Yield % is 24.33, which is 203% above median its 10-year median of 8.03 and 609.3% above the Drug Manufacturers industry median of 3.43. ACME Laboratories' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For ACME Laboratories (DHA:ACMELAB), the current OCF Yield % is 24.33 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ACME Laboratories (DHA:ACMELAB) Overvalued in 2026?
Based on GuruFocus' analysis, ACME Laboratories stock appears to be undervalued.
The current stock price of BDT82.60 is trading 34% below its estimated GF Value™ of BDT125.08.
GuruFocus considers ACME Laboratories to be Possible Value Trap.
Key valuation signals for DHA:ACMELAB:
OCF Yield %: 24.33 (203% above median its 10-year median of 8.03)
GF Value™: BDT125.08 vs. price of BDT82.60 (34% below fair value)
Industry Position: 609.3% above the Drug Manufacturers median (#52 of 1007)
No single metric tells the full story. See the DHA:ACMELAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, sachet products; veterinary drugs comprising dosages form like bolus, liquid,injection, water-soluble powder, premix and herbal drugs comprising dosages form like liquid, capsule, tablet, cream. The products of the company are sold in domestic and international markets.
82GF Score
Get the complete analysis for DHA:ACMELAB
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ACMELAB has been successfully added to your 
